Beni Rovinski PhD

Managing Director

Current board roles

Aurinia Pharmaceuticals
Antiva Biosciences
G1 Therapeutics

Previous board roles

Vascular Pharaceuticals
KAI Pharmaceuticals
Aegera Pharmaceuticals
Avalon Pharmaceuticals
Cervelo Pharmaceuticals
Health Hero Network
Immunicon
IMMC
Inovise Medical, Inc.
Morphotek
Protana
Signature Biosciences
SGX Pharmaceuticals

Education

PhD (biochemistry) McGill University Montréal, Québec
BSc (biochemistry) Rice University, Houston, Texas
Post-doctoral studies in molecular oncology and retrovirology, Ontario Cancer Institute, Toronto, Ontario

Industry affiliations

Advisor, Fitzsimons BioBusiness Partners
American Association for the Advancement of Science
Canadian Association of HIV Researchers
International AIDS Society
Life Sciences Ontario - Director
National Venture Capital Association
Ontario Personalized Medicine Network
Rice University Alliance for Technology and Entrepreneurship
The American Society for Microbiology
Toronto Region Board of Trade Human Health Sciences Steering Committee